You Searched For "Novavax" and got 20 results
Sort By:
3 mins read
US-based biotechnology company Novavax’s COVID-19 shot is 90% effective
US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent effica…
2 mins read
More than 3.3 million people lost life to COVID-19 in 2021 — more than HIV, malaria and tuberculosis related deaths combined in 2020
The World Health Organisation (WHO), on Tuesday, revealed that more than 3.3 million people lost th…
2 mins read
Novavax says its coronavirus shot is 90% effective
These are Insider's biggest healthcare stories for June 14.
Lydia Ramsey Pflanzer
2 mins read
AstraZeneca partners with Oxford university to roll out human trials for COVID-19 booster shots against Beta-variant
British-Swedish biopharmaceutical firm AstraZeneca has in partnership with the University of Oxford…
3 mins read
Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use
Novavax fell behind rivals like Pfizer and Moderna, and the biotech's launch timeline remains hazy.
Andrew Dunn
1 min read
Novavax stock plunges 25% after the COVID-19 vaccine maker warns it could go out of business
Novavax shares sank after the COVID-19 vaccine maker warned it has "substantial doubt" about its ab…
Zinya Salfiti
2 mins read
A new COVID shot is more effective against current variants and may have fewer side effects
The FDA approved an updated COVID-19 vaccine from Novavax. The vaccine is more effective at protect…
Kate Hull
1 min read
Serum Institute's second COVID-19 vaccine 'Covavax' likely to be launched in September
Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax …
7 mins read
Making vaccines available to Indians may not be enough, it depends on how judiciously we employ them
Opinions may be divided on the exact reason behind this resurgence. Still, as more and more dat…
2 mins read
Novavax's COVID-19 vaccine was 89.7% effective in a large trial, and worked against the contagious virus variant first found in the UK
US biotech Novavax said its vaccine was 48.6% effective in a smaller trial in South Africa, where a…
Dr. Catherine Schuster-Bruce
2 mins read
US-based Novavax says its vaccine is 96% effective, after phase 3 trials, against COVID-19
The vaccine, NVX-CoV2373, was found 86.3 per cent effective against the B.1.1.7/501Y.V1 variant …
2 mins read
Novavax's COVID-19 vaccine could be authorized as early as May, its CEO said. A trial suggests it is 89% effective, though slightly less so against contagious variants.
CEO Stanley Erck said Novavax's COVID-19 vaccine could be authorized in the UK first before the FDA…
Grace Dean
5 mins read
What we know about vaccines and variants
These are the top stories written by Business Insider's healthcare team for the week ending January…
Lydia Ramsey Pflanzer
2 mins read
Fauci calls COVID-19 shots' diminished results against the mutated virus 'a wake-up call'
Some coronavirus vaccines don't work as well against a variant of the virus first identified in Sou…
Allison DeAngelis
2 mins read
Novavax COVID-19 vaccine found 89.3% effective in UK trials
US-based biotechnology company Novavax on Friday announced that its Covid-19 vaccine was 89.3 per c…
3 mins read
Novavax says its coronavirus vaccine was highly effective in a UK trial, but it didn't work nearly as well against the variant first found in South Africa
The shot was much less effective in a smaller trial in South Africa, where it faced a new variant o…
Lydia Ramsey Pflanzer
3 mins read
Bill Gates says several more COVID-19 vaccine frontrunners will likely be highly effective, boosting worldwide access to a shot
These vaccines, developed by AstraZeneca, Novavax, and J&J,"are a little bit easier to scale up pro…
Andrew Dunn
3 mins read
What we know about new coronavirus variant 'Eris,' from symptoms to how fast it's spreading
A rapidly spreading coronavirus variant, "Eris," is now thought to be the dominant strain in the US…
Kate Hull
2 mins read
Moderna, BioNTech, and Novavax plunge after President Biden says the COVID-19 pandemic 'is over'
"The pandemic is over. We still have a problem with COVID. We're still doing a low of work on it. B…
Matthew Fox
2 mins read
Novavax begins clinical trial of Covid-19 vaccine in Australia
US-based biotechnology company Novavax has started enrolling participants in Australia for a clinic…